CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 88 enrolled
Drug / intervention
Intranasal lavage with hypochlorous acid solutionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05950295
NCT05950295N/ACompleted
CompareCT.gov

Intranasal Lavage With Hypochlorous Acid Safely Reduces the Symptoms in the Ambulatory Patient With COVID-19.

Monique Lisa Abner·observational·Posted Jul 18, 2023·Updated Jul 18, 2023

In Brief

An observational study evaluating Intranasal lavage with hypochlorous acid solution for COVID-19. Completed, enrolled 88 participants across 1 site.

Detailed Summary

The goal of this observational study is to determine if intranasal lavage reduces symptoms in adults with COVID-19. The main question is can a hypochlorous acid solution reduce the symptoms of COVID-19. Participants will asked to do the following: * Irrigate each nostril once a day for ten days with a hypochlorous acid solution. * Write a daily record of the presence or absence of symptoms such as fever, headache, chills, nausea, or change in sense of smell. * After ten days, return the daily log in the mail to the investigator.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCOVID-19
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedJul 18, 2023
Enrollment StartSep 24, 2020
Primary CompletionMar 13, 2021
Study CompletionApr 13, 2021
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 3.0 years ago

Interventions

Intranasal lavage with hypochlorous acid solutionother

intranasal lavage for ten days